The goal of SPL Medical is to develop and research new technologies that sustainably improve imaging procedures in diagnostics, so that lymph node metastases and inflammatory activities in the body can be detected more precisely and significantly earlier, patient lives can be extended and the quality of life of those affected can be noticeably increased. SPL Medical is a spin-off from Radboud University Nijmegen and is supported by Oost NL and b.e.imaging, a German specialist in contrast media.
The revolution
in early detection of metastases.The revolution
in early detection of metastases.DETECTING
METASTASES
TODAY.Conventional MRI or CT only show lymph node metastases of about 8 mm in size.
DETECTING
METASTASES WITH
FERUMOXTRAN.See smaller.The new active ingredient enables for the first time to detect metastases with a diameter of just 2 mm.
DETECTING
METASTASES
IN NANOPARTICLE MRI.SEE MORE.Significantly more affected areas can be seen on the clear and high-contrast MRI image.
More targeted
prognosis
for therapy.SEE SOONER.Significant time savings through earlier and more precise treatment.
Animation überspringen
In order to register the globally novel agent in Europe and Germany, a registration trial with Ferrotran® is currently underway at several well-known European clinics for the detection of pelvic lymph node metastases in prostate cancer patients. To date, more than 700 prostate cancer patients have been diagnosed with Ferrotran® , giving them earlier and more specific treatment and a significantly higher chance of recovery.
SPL Medical B.V. announced today further results of the pivotal phase III study PROSTAPROGRESS (EudraCT 2018-004310-18), aiming to assess the diagnostic accuracy of Ferumoxtran enhanced Magnetic Resonance Imaging (MRI) for lymph node detection in prostate cancer patients.
SPL Medical B.V. announced today the headline results of the pivotal phase III study PROSTAPROGRESS (EudraCT 2018-004310-18), aiming to assess the diagnostic accuracy of Ferumoxtran enhanced Magnetic Resonance Imaging (MRI) for lymph node detection in prostate cancer patients.
SPL Medical announced today the publication and online availability of the full paper in European Radiology about the use of Ferrotran® for lymph node detection in pancreatic and other adenocarcinoma.
